Name | Company Name | Weight % | Market Value | Market Cap | Yearly Gain | Overall Rating |
|---|---|---|---|---|---|---|
| Fanuc Corporation | 2.47% | $449.08K | ¥4.77T | 25.30% | 76 Outperform | |
| HOYA | 2.43% | $440.89K | ¥8.61T | 22.09% | 76 Outperform | |
| Baidu, Inc. Class A | 2.29% | $415.43K | HK$335.25B | 34.99% | 71 Outperform | |
| GlaxoSmithKline | 2.23% | $405.25K | £71.92B | 28.60% | 77 Outperform | |
| Tencent Holdings | 2.13% | $387.21K | HK$5.71T | 48.35% | 79 Outperform | |
| ― | 1.99% | $361.08K | ― | ― | ― | |
| Siemens Healthineers AG | 1.99% | $360.92K | €54.95B | 6.07% | 79 Outperform | |
| Bureau Veritas | 1.94% | $352.21K | €13.02B | -3.95% | 76 Outperform | |
| Yum China Holdings | 1.93% | $349.90K | $16.53B | -7.28% | 74 Outperform | |
| Salesforce | 1.93% | $349.41K | $242.23B | -14.47% | 79 Outperform |